Skip to main content
. 2018 Aug 10;35:167–177. doi: 10.1016/j.ebiom.2018.08.011

Fig. 7.

Fig. 7

Proposed models for SRRM4 in driving t-NEPC development through different mechanisms. A schematic diagram illustrates two mechanisms of SRRM4 in driving the development of t-NEPC tumors. AdPC, prostate adenocarcinoma; t-NEPC, treatment-induced neuroendocrine prostate cancer; ARPI, androgen receptor pathway inhibitors; NE, neuroendocrine; LE, luminal epithelial.